Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Exhaled phospholipid transfer protein and hepatocyte growth factor receptor in lung adenocarcinoma

Fig. 1

Overview of workflow. A Patient enrollment, describes sampling of exhaled breath particles (EBP) and plasma from lung adenocarcinoma patients (LUAD) and non-cancer surgical controls (Co). Samples were collected preoperatively for both cohorts and at 1-month post-surgery for the LUAD cohort. B Validation, (1) Proximity extension assay (PEA) technology. (2) Standard sandwich enzyme-linked immunosorbent assay with specific antibodies for hepatocyte growth factor (MET) in plasma from all patients and timepoints (n = 49). (3) Deposited microarray data were used for validation of proteins in EBP

Back to article page